eLife · 2017 · 36 citations · 24 references
MedicineMolecular BiologyOphthalmologyCell SignalingGene ExpressionGene FunctionPhotoreceptor Gene FunctionPhotoreceptor PhysiologyRetinal DegenerationRetinal DiseaseRetinal PharmacotherapyGene Regulation In PhotoreceptorsPhotoreceptor NeuroprotectionRetinal Degeneration MechanismsRetinal Photoreceptor PhysiologyRetinitis Pigmentosa TherapyRod Photoreceptor FunctionTherapeutic ModulationTranscription Factors In Photoreceptors
Regulation of rod gene expression has emerged as a potential therapeutic strategy to treat retinal degenerative diseases like retinitis pigmentosa (RP). We previously reported on a small molecule modulator of the rod transcription factor Nr2e3, Photoregulin1 (PR1), that regulates the expression of photoreceptor-specific genes. Although PR1 slows the progression of retinal degeneration in models of RP in vitro, in vivo analyses were not possible with PR1. We now report a structurally unrelated compound, Photoregulin3 (PR3) that also inhibits rod photoreceptor gene expression, potentially though Nr2e3 modulation. To determine the effectiveness of PR3 as a potential therapy for RP, we treated RhoP23H mice with PR3 and assessed retinal structure and function. PR3-treated RhoP23H mice showed significant structural and functional photoreceptor rescue compared with vehicle-treated littermate control mice. These results provide further support that pharmacological modulation of rod gene expression provides a potential strategy for the treatment of RP.
24
Nrl is required for rod photoreceptor development
Alan J. Mears, Mineo Kondo, Prabodha K. Swain et al. · Nature Genetics · 2001 · 921 citations
Population genetic studies of retinitis pigmentosa.
Joann A. Boughman, P. M. Conneally, W E Nance · PubMed · 1980 · 319 citations · Full text
Sanae Sakami, Tadao Maeda, Grzegorz Bereta et al. · Journal of Biological Chemistry · 2011 · 304 citations · Full text
Medicine, Genetics, Ophthalmology +17